InflamaX Pharmaceuticals
Company Details
Status: Private
Employees: 1-10
Location:
Guangzhou, Guangdong, China
Type:
sample
Technology:
sample
About: Founded in 2022, InflamaX is a clinical-stage biotechnology company located in Guangzhou that specializes in making new medicines that target immuno-inflammation as a means for treating various diseases including cancers, pain, neurological diseases, and osteoarthritis. It is our belief that the tissue microenvironment determines how the immune system responds to its surrounding environment. Small changes in the extracellular matrix can cause an over-reaction or under-reaction in the immune/inflammatory response resulting in disease. Our drugs target key mechanisms and pathways in the tissue microenvironment that correct this incorrect immune/inflammatory response. We currently have 4 clinical candidate drugs in our portfolio and also have a preclinical drug discovery arm that is making new compounds against various immuno-inflammation-based targets.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
InflamaX Pharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.